OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
13
Results
Show all
Save search
Copy query
Show results for
Unknown
(13)
Publication Date
Release Date
2018
(3)
2024
(2)
2023
(2)
2015
(2)
2025
(1)
2019
(1)
2017
(1)
2010
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Early High-Dose Vitamin D
3
for Critically Ill, Vitamin D-Deficient Patients.
Not available
S-EPMC7306117
|
biostudies-literature
Cite
Precision medicine screening using whole-genome sequencing and advanced imaging to identify disease risk in adults.
Not available
S-EPMC5889622
|
biostudies-literature
Cite
Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score.
Not available
S-EPMC5360219
|
biostudies-literature
Cite
Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease.
Not available
S-EPMC4677995
|
biostudies-literature
Cite
Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.
Not available
S-EPMC5759091
|
biostudies-literature
Cite
Acetaminophen for Prevention and Treatment of Organ Dysfunction in Critically Ill Patients With Sepsis: The ASTER Randomized Clinical Trial.
Not available
S-EPMC11304120
|
biostudies-literature
Cite
Peripheral Vasopressor Use in Early Sepsis-Induced Hypotension.
Not available
S-EPMC12391982
|
biostudies-literature
Cite
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.
Not available
S-EPMC10685906
|
biostudies-literature
Cite
Noninvasive Ventilation for Preoxygenation during Emergency Intubation.
Not available
S-EPMC11282951
|
biostudies-literature
Cite
Vitrectomy outcomes in eyes with diabetic macular edema and vitreomacular traction.
Not available
S-EPMC2911350
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets